<p><strong>Adults and adolescents from 16 years of age</strong>: The recommended starting dose is 250 mg twice daily which should be increased to an initial therapeutic dose of 500 mg twice daily after two weeks. The dose can be further increased by 250 mg twice daily every two weeks depending upon the clinical response. The maximum dose is 1500 mg twice daily.<br />
<br />
<strong>Adults (&ge;18 years) and adolescents (12 to 17 years) weighing 50 kg or more</strong>: The initial therapeutic dose is 500 mg twice daily. This dose can be started on the first day of treatment. Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increases or decrease every two to four weeks.<br />
<br />
<strong>Pediatric population</strong>: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Oral solution is the preferred formulation for use in this population. In addition, the available dose strengths of the tablets are not appropriate for initial treatment in children weighing less than 25 kg, for patients unable to swallow tablets or for the administration of doses below 250 mg. In all of the above cases, oral solution should be used.<br />
&nbsp;</p>

<ul>
	<li><strong>Monotherapy</strong>: The safety and efficacy of levetiracetam in children and adolescents below 16 years as monotherapy treatment have not been established.</li>
	<li><strong>Add-on therapy</strong>: Oral solution is the preferred formulation for use in infants and children under the age of 6 years. For children 6 years and above, oral solution should be used for doses under 250 mg, for doses not in multiples of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets. The lowest effective dose should be used. The starting dose for a child or adolescent of 25 kg should be 250 mg twice daily with a maximum dose of 750 mg twice daily. Dosing for children 50 kg or greater is the same as in adults.</li>
	<li><strong>Add-on therapy</strong>: For&nbsp;infants aged from 1 month to less than 6 months: The oral solution is the formulation to use in infants.</li>
</ul>

<p>&nbsp;</p>

<p><strong>Administration</strong></p>

<p>The flm-coated tablets must be taken orally, swallowed with a sufcient quantity of liquid and may be taken with or without food. The daily dose is administered in two equally divided doses.</p>